Successful Biological Treatment of a Patient With Psoriasis and HIV.

The use of biological agents for the management of chronic dermatological pathologies such as psoriasis is becoming more common every day. Until now, antibodies against tumor necrosis factors (TNF-α) inhibitors, interleukin IL-17 inhibitors, IL-12/23 inhibitors, and IL-23 inhibitors have been marketed as biological therapies for psoriasis, showing excellent results with a minimal number of adverse events. Initially, the first biological treatments were associated primarily with opportunistic infections.

IgA Vasculitis Associated With Levofloxacin Use in an Adult Female: A Case Report.

Immunoglobulin A (IgA) vasculitis, once known as Henoch-Schönlein purpura in recognition of the physicians who first identified it, is an acute form of vasculitis, associated with a deposition of immune complexes, self-limited that affects small-caliber vessels. It usually occurs in children and rarely in adults. This disease can be induced by multiple factors such as exposure to certain infectious antigens such as viruses or bacteria, drugs, and toxins, and even genetic predisposition has been described.